Juno Therapeutics Enters Battle Over CAR Cancer Immunotherapy Technology
This article was originally published in The Pink Sheet Daily
Executive Summary
University of Pennsylvania seeks court order that its cancer immunotherapy does not infringe St. Jude’s patent; Juno, which licensed the patent for the potential leukemia treatment, has joined the settlement talks.